Shmulik Hess
Directeur des opérations chez MEDIWOUND LTD.
Postes actifs de Shmulik Hess
Sociétés | Poste | Début | Fin |
---|---|---|---|
MEDIWOUND LTD. | Directeur des opérations | 01/12/2023 | - |
Historique de carrière de Shmulik Hess
Anciens postes connus de Shmulik Hess
Sociétés | Poste | Début | Fin |
---|---|---|---|
Valin Technologies Ltd. | Directeur Général | 01/01/2010 | 01/11/2018 |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Directeur Général | 03/03/2010 | 01/09/2011 |
Fondateur | 01/01/2008 | 01/09/2011 | |
SCIGEN LIMITED | Directeur des opérations | 01/08/2008 | 01/03/2010 |
ENLIVEX THERAPEUTICS LTD. | Directeur Général | - | - |
Tabby Therapeutics Ltd.
Tabby Therapeutics Ltd. BiotechnologyHealth Technology Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad. | Directeur Général | - | - |
Formation de Shmulik Hess
The Hebrew University of Jerusalem | Doctorate Degree |
Statistiques
Internationale
Israël | 7 |
Singapour | 2 |
Opérationnelle
Chief Executive Officer | 4 |
Chief Operating Officer | 2 |
Founder | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
MEDIWOUND LTD. | Health Technology |
ENLIVEX THERAPEUTICS LTD. | Health Technology |
Entreprise privées | 4 |
---|---|
SciGen Pte Ltd.
SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
Valin Technologies Ltd. | |
Tabby Therapeutics Ltd.
Tabby Therapeutics Ltd. BiotechnologyHealth Technology Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad. | Health Technology |
- Bourse
- Insiders
- Shmulik Hess
- Expérience